Correction: Diuretic dose trajectories in dilated cardiomyopathy: prognostic implications (Clinical Research in Cardiology, (2023), 112, 3, (419-430), 10.1007/s00392-022-02126-8)

Vincenzo Nuzzi; Antonio Cannatà; Pierpaolo Pellicori; Paolo Manca; Davide Stolfo; Caterina Gregorio; Giulia Barbati; Daniel I. Bromage; Theresa McDonagh; John G.F. Cleland; Marco Merlo; Gianfranco Sinagra

doi:10.1007/s00392-022-02133-9

Correction: Diuretic dose trajectories in dilated cardiomyopathy: prognostic implications (Clinical Research in Cardiology, (2023), 112, 3, (419-430), 10.1007/s00392-022-02126-8)

Vincenzo Nuzzi
, Antonio Cannatà
, Pierpaolo Pellicori
, Paolo Manca
, Davide Stolfo
, Caterina Gregorio
, Giulia Barbati
, Daniel I. Bromage
, Theresa McDonagh
, John G.F. Cleland
, Marco Merlo^*
, Gianfranco Sinagra

^*Corresponding author for this work

Azienda Sanitaria Universitaria Integrata di Trieste
Karolinska Institute
University of Trieste
Polytechnic University of Milan
University of Glasgow

Research output: Contribution to journal › Comment/debate › peer-review

2 Citations (Scopus)

Abstract

Within the abstract, the following phrase in the ‘Methods’ section “According to FED trajectory, patients were classified as (i) dose (FED increase by ≥ 50% or newly initiated);” was corrected to read “According to FED trajectory, patients were classifed as (i) dose ↑ (FED increase by ≥ 50% or newly initiated);”. In the ‘Results’ section of the abstract, the sentence“Baseline FED was independently associated with outcome (HR per 20 mg increase: 1.12 [95% CI 1.04–1.22, p = 0.003].” was corrected to “Baseline FED was independently associated with outcome (HR per 20 mg increase: 1.12 [95% CI 1.04–1.22], p = 0.003).” Finally, in Table 1, the LVEF, % for Dose↓ patients was given incorrectly when it should have been “28 (22–34)” and the N value has been corrected from “263” to “282”. The original article has been corrected.

Original language	English
Pages (from-to)	454
Number of pages	1
Journal	Clinical Research in Cardiology
Volume	112
Issue number	3
DOIs	https://doi.org/10.1007/s00392-022-02133-9
Publication status	Published - 6 Dec 2022

Access to Document

10.1007/s00392-022-02133-9

Cite this

Nuzzi, V., Cannatà, A., Pellicori, P., Manca, P., Stolfo, D., Gregorio, C., Barbati, G., Bromage, D. I., McDonagh, T., Cleland, J. G. F., Merlo, M., & Sinagra, G. (2022). Correction: Diuretic dose trajectories in dilated cardiomyopathy: prognostic implications (Clinical Research in Cardiology, (2023), 112, 3, (419-430), 10.1007/s00392-022-02126-8). Clinical Research in Cardiology, 112(3), 454. https://doi.org/10.1007/s00392-022-02133-9

@article{5a9ba578302a4962a15c3108aeff1192,

title = "Correction: Diuretic dose trajectories in dilated cardiomyopathy: prognostic implications (Clinical Research in Cardiology, (2023), 112, 3, (419-430), 10.1007/s00392-022-02126-8)",

abstract = "Within the abstract, the following phrase in the {\textquoteleft}Methods{\textquoteright} section “According to FED trajectory, patients were classified as (i) dose (FED increase by ≥ 50\% or newly initiated);” was corrected to read “According to FED trajectory, patients were classifed as (i) dose ↑ (FED increase by ≥ 50\% or newly initiated);”. In the {\textquoteleft}Results{\textquoteright} section of the abstract, the sentence“Baseline FED was independently associated with outcome (HR per 20 mg increase: 1.12 [95\% CI 1.04–1.22, p = 0.003].” was corrected to “Baseline FED was independently associated with outcome (HR per 20 mg increase: 1.12 [95\% CI 1.04–1.22], p = 0.003).” Finally, in Table 1, the LVEF, \% for Dose↓ patients was given incorrectly when it should have been “28 (22–34)” and the N value has been corrected from “263” to “282”. The original article has been corrected.",

author = "Vincenzo Nuzzi and Antonio Cannat{\`a} and Pierpaolo Pellicori and Paolo Manca and Davide Stolfo and Caterina Gregorio and Giulia Barbati and Bromage, \{Daniel I.\} and Theresa McDonagh and Cleland, \{John G.F.\} and Marco Merlo and Gianfranco Sinagra",

note = "Publisher Copyright: {\textcopyright} 2022 The Author(s).",

year = "2022",

month = dec,

day = "6",

doi = "10.1007/s00392-022-02133-9",

language = "English",

volume = "112",

pages = "454",

journal = "Clinical Research in Cardiology",

issn = "1861-0684",

publisher = "Springer",

number = "3",

}

Nuzzi, V, Cannatà, A, Pellicori, P, Manca, P, Stolfo, D, Gregorio, C, Barbati, G, Bromage, DI , McDonagh, T, Cleland, JGF, Merlo, M & Sinagra, G 2022, 'Correction: Diuretic dose trajectories in dilated cardiomyopathy: prognostic implications (Clinical Research in Cardiology, (2023), 112, 3, (419-430), 10.1007/s00392-022-02126-8)', Clinical Research in Cardiology, vol. 112, no. 3, pp. 454. https://doi.org/10.1007/s00392-022-02133-9

Correction: Diuretic dose trajectories in dilated cardiomyopathy: prognostic implications (Clinical Research in Cardiology, (2023), 112, 3, (419-430), 10.1007/s00392-022-02126-8). / Nuzzi, Vincenzo; Cannatà, Antonio; Pellicori, Pierpaolo et al.
In: Clinical Research in Cardiology, Vol. 112, No. 3, 06.12.2022, p. 454.

Research output: Contribution to journal › Comment/debate › peer-review

TY - JOUR

T1 - Correction

T2 - Diuretic dose trajectories in dilated cardiomyopathy: prognostic implications (Clinical Research in Cardiology, (2023), 112, 3, (419-430), 10.1007/s00392-022-02126-8)

AU - Nuzzi, Vincenzo

AU - Cannatà, Antonio

AU - Pellicori, Pierpaolo

AU - Manca, Paolo

AU - Stolfo, Davide

AU - Gregorio, Caterina

AU - Barbati, Giulia

AU - Bromage, Daniel I.

AU - McDonagh, Theresa

AU - Cleland, John G.F.

AU - Merlo, Marco

AU - Sinagra, Gianfranco

PY - 2022/12/6

Y1 - 2022/12/6

N2 - Within the abstract, the following phrase in the ‘Methods’ section “According to FED trajectory, patients were classified as (i) dose (FED increase by ≥ 50% or newly initiated);” was corrected to read “According to FED trajectory, patients were classifed as (i) dose ↑ (FED increase by ≥ 50% or newly initiated);”. In the ‘Results’ section of the abstract, the sentence“Baseline FED was independently associated with outcome (HR per 20 mg increase: 1.12 [95% CI 1.04–1.22, p = 0.003].” was corrected to “Baseline FED was independently associated with outcome (HR per 20 mg increase: 1.12 [95% CI 1.04–1.22], p = 0.003).” Finally, in Table 1, the LVEF, % for Dose↓ patients was given incorrectly when it should have been “28 (22–34)” and the N value has been corrected from “263” to “282”. The original article has been corrected.

AB - Within the abstract, the following phrase in the ‘Methods’ section “According to FED trajectory, patients were classified as (i) dose (FED increase by ≥ 50% or newly initiated);” was corrected to read “According to FED trajectory, patients were classifed as (i) dose ↑ (FED increase by ≥ 50% or newly initiated);”. In the ‘Results’ section of the abstract, the sentence“Baseline FED was independently associated with outcome (HR per 20 mg increase: 1.12 [95% CI 1.04–1.22, p = 0.003].” was corrected to “Baseline FED was independently associated with outcome (HR per 20 mg increase: 1.12 [95% CI 1.04–1.22], p = 0.003).” Finally, in Table 1, the LVEF, % for Dose↓ patients was given incorrectly when it should have been “28 (22–34)” and the N value has been corrected from “263” to “282”. The original article has been corrected.

UR - https://www.scopus.com/pages/publications/85143741974

U2 - 10.1007/s00392-022-02133-9

DO - 10.1007/s00392-022-02133-9

M3 - Comment/debate

C2 - 36472647

AN - SCOPUS:85143741974

SN - 1861-0684

VL - 112

SP - 454

JO - Clinical Research in Cardiology

JF - Clinical Research in Cardiology

IS - 3

ER -

Correction: Diuretic dose trajectories in dilated cardiomyopathy: prognostic implications (Clinical Research in Cardiology, (2023), 112, 3, (419-430), 10.1007/s00392-022-02126-8)

Abstract

Access to Document

Other files and links

Fingerprint

Cite this